JPMorgan Chase & Co’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.61B | Sell |
|
|||||
|
2025
Q1 | $3.76B | Buy |
|
|||||
|
2024
Q4 | $2.54B | Sell |
|
|||||
|
2024
Q3 | $3.22B | Buy |
|
|||||
|
2024
Q2 | $3.09B | Buy |
|
|||||
|
2024
Q1 | $2.52B | Buy |
|
|||||
|
2023
Q4 | $2.29B | Sell |
|
|||||
|
2023
Q3 | $2.12B | Buy |
|
|||||
|
2023
Q2 | $2.1B | Sell |
|
|||||
|
2023
Q1 | $2B | Buy |
|
|||||
|
2022
Q4 | $1.59B | Buy |
|
|||||
|
2022
Q3 | $1.41B | Sell |
|
|||||
|
2022
Q2 | $1.48B | Buy |
|
|||||
|
2022
Q1 | $1.26B | Buy |
|
|||||
|
2021
Q4 | $980M | Buy |
|
|||||
|
2021
Q3 | $764M | Sell |
|
|||||
|
2021
Q2 | $895M | Buy |
|
|||||
|
2021
Q1 | $689M | Buy |
|
|||||
|
2020
Q4 | $612M | Buy |
|
|||||
|
2020
Q3 | $605M | Buy |
|
|||||
|
2020
Q2 | $613M | Sell |
|
|||||
|
2020
Q1 | $522M | Sell |
|
|||||
|
2019
Q4 | $566M | Sell |
|
|||||
|
2019
Q3 | $572M | Sell |
|
|||||
|
2019
Q2 | $774M | Sell |
|
|||||
|
2019
Q1 | $1.25B | Sell |
|
|||||
|
2018
Q4 | $1.19B | Buy |
|
|||||
|
2018
Q3 | $1.37B | Buy |
|
|||||
|
2018
Q2 | $1.15B | Sell |
|
|||||
|
2018
Q1 | $1.3B | Sell |
|
|||||
|
2017
Q4 | $1.41B | Buy |
|
|||||
|
2017
Q3 | $1.39B | Buy |
|
|||||
|
2017
Q2 | $1.08B | Sell |
|
|||||
|
2017
Q1 | $1.02B | Sell |
|
|||||
|
2016
Q4 | $781M | Sell |
|
|||||
|
2016
Q3 | $962M | Sell |
|
|||||
|
2016
Q2 | $1.05B | Buy |
|
|||||
|
2016
Q1 | $929M | Sell |
|
|||||
|
2015
Q4 | $1.59B | Buy |
|
|||||
|
2015
Q3 | $1.2B | Buy |
|
|||||
|
2015
Q2 | $1.31B | Buy |
|
|||||
|
2015
Q1 | $1.2B | Sell |
|
|||||
|
2014
Q4 | $1.24B | Sell |
|
|||||
|
2014
Q3 | $1.19B | Buy |
|
|||||
|
2014
Q2 | $912M | Buy |
|
|||||
|
2014
Q1 | $538M | Sell |
|
|||||
|
2013
Q4 | $682M | Buy |
|
|||||
|
2013
Q3 | $578M | Buy |
|
|||||
|
2013
Q2 | $551M | Buy |
|